The long-awaited report of the Eastern Cooperative Oncology Group–American College of Radiology Imaging Network (ECOG-ACRIN) 1308 study, 1 although interesting, was troubling for numerous reasons, ...
Geriatric assessment tools, including CGA, offer superior prognostic value over traditional performance measures in older DLBCL patients. Comprehensive geriatric assessments reveal frailty levels, ...
ECOG performance status is an important risk factor for early mortality in metastatic castration-resistant prostate cancer (mCRPC). Patients with metastatic castration-resistant prostate cancer (mCRPC ...
Lead investigator Kristen R. Spencer, DO, MPH, a medical oncologist at New York University's Langone Perlmutter Cancer Center and chair of the ECOG-ACRIN Genomics Subcommittee. Another ECOG-ACRIN ...
Patients with ECOG performance status of 1 reported worse global health status, quality of life, and physical functioning than those with a status of 0. The RATIONALE-305 trial showed Tevimbra plus ...
Early-phase clinical trials (EP-CTs) are designed to determine optimal dosing, tolerability, and preliminary activity of novel cancer therapeutics. Little is known about the time that patients spend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results